Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities.

Lohia, Aayushi; Sahel, Deepak Kumar; Salman, Mohd; Singh, Vivek; Mariappan, Indumathi; Mittal, Anupama; Chitkara, Deepak

Lohia, Aayushi; Sahel, Deepak Kumar; Salman, Mohd; Singh, Vivek; Mariappan, Indumathi; Mittal, Anupama; Chitkara, Deepak.

Afiliación

Lohia A; Department of Pharmacy, Birla Institute of Technology and Science, Pilani (BITS-Pilani), Vidya Vihar Campus, Pilani 333031, India.
Sahel DK; Department of Pharmacy, Birla Institute of Technology and Science, Pilani (BITS-Pilani), Vidya Vihar Campus, Pilani 333031, India.
Salman M; Prof. Brien Holden Eye Research Center, Champalimaud Translational Centre for Eye Research, L.V. Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad 500034, India.
Singh V; Prof. Brien Holden Eye Research Center, Champalimaud Translational Centre for Eye Research, L.V. Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad 500034, India.
Mariappan I; Prof. Brien Holden Eye Research Center, Champalimaud Translational Centre for Eye Research, L.V. Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad 500034, India.
Mittal A; Department of Pharmacy, Birla Institute of Technology and Science, Pilani (BITS-Pilani), Vidya Vihar Campus, Pilani 333031, India.
Chitkara D; Department of Pharmacy, Birla Institute of Technology and Science, Pilani (BITS-Pilani), Vidya Vihar Campus, Pilani 333031, India.

Asian J Pharm Sci ; 17(2): 153-176, 2022 Mar.

Article en En | MEDLINE | ID: mdl-36320315

Palabras clave

CRISPR/Cas9; Gene editing; Non-viral nanocarriers; Retinal dystrophies

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Asian J Pharm Sci Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google